886362-45-4 Usage
Uses
Used in Pharmaceutical Industry:
8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPOINIC ACID is used as a key intermediate in the synthesis of various drugs. Its unique structure and reactivity allow for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPOINIC ACID is utilized as a building block for the creation of novel agrochemicals. Its properties enable the synthesis of compounds with potential applications in crop protection and pest control.
Used in Organic Synthesis:
8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPOINIC ACID is employed as a versatile intermediate in organic synthesis for the preparation of a wide range of organic compounds. Its BOC protecting group allows for selective reactions, making it a valuable tool in the synthesis of complex organic molecules.
Used in Fine Chemicals Industry:
In the fine chemicals industry, 8-N-BOC-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-PROPOINIC ACID is used as a crucial component in the production of specialty chemicals. Its unique properties and reactivity contribute to the development of high-value compounds for various applications, including fragrances, dyes, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 886362-45-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 886362-45:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*2)+(2*4)+(1*5)=214
214 % 10 = 4
So 886362-45-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H22N2O4/c1-16(2,3)22-15(21)18-10-4-5-11-6-7-12(17-14(11)18)8-9-13(19)20/h6-7H,4-5,8-10H2,1-3H3,(H,19,20)
886362-45-4Relevant academic research and scientific papers
Pyrrolidine integrin regulator and application thereof
-
Paragraph 0271-0273, (2021/09/08)
Disclosed are a compound as represented by formula I, and a racemate, a stereoisomer, a tautomer, an isotopic marker, a nitrogen oxide, a solvate, a polymorph, a metabolite, an ester, and a prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and the medical use thereof. The structure of formula I is as follows:
CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS
-
, (2018/05/27)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds are antagonists to αv- containing integrins. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition associated with dysregulation of av-containing integrins, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders, by using the compounds and pharmaceutical compositions.
